When the Fund Values Itself, the Number Is Not a Market Price. It Is a Management Decision.

When the Fund Values Itself, the Number Is Not a Market Price. It Is a Management Decision.

📖 About This Summary

This article is based on the video "BlackRock Department of Justice Probe Just Announced: The Unwind in Private Credit Has Begun" by Ox Talks. All content is edited and annotated by Time Health Capital.

Private credit became one of the most popular destinations for yield-seeking capital over the past decade. High-income investors were told the asset class offered stability, consistent returns, and lower correlation to public market volatility. That pitch was compelling — particularly to physicians looking to build income outside of clinical work.

What was less visible was the incentive structure underneath. The funds valued their own assets. The fees were calculated on those self-assigned values. And no independent market was checking the numbers in between quarterly reports.

The Department of Justice has now begun asking questions. The implications extend well beyond one fund.

"If people are mismarking in order to generate fees, that's a no-no." — Jay Clayton, Southern District of New York

🏦 What the DOJ Is Actually Investigating

Federal prosecutors from the Manhattan U.S. Attorney's Office have brought in executives from BlackRock TCP Capital Corporation (TCPC) for questioning.

TCPC is a Business Development Company — a publicly traded private credit vehicle. It manages approximately $1.8 billion across roughly 150 portfolio companies, lending to middle market businesses that typically lack access to traditional public debt markets.

The investigation is not about loan defaults. It is about how the fund valued its assets internally — and whether those valuations were accurate.

Private credit funds do not trade like stocks. There is no constant public market price. Valuations are assigned by the firms themselves using internal models, assumptions, and committee decisions.

Jay Clayton, who now runs the Southern District of New York, flagged exactly this issue last year when he warned that regulators were increasingly focused on how private credit firms value their assets. His statement this week was direct: if firms are mismarking assets to generate larger management fees, that is the concern that draws federal prosecutors.

placeholder image

⚠️ The Incentive Structure Nobody Was Talking About

To understand why this probe matters beyond one fund, the fee structure of private credit has to be understood clearly.

Management fees in private credit are typically calculated as a percentage of the fund's total asset value. A fund managing $10 billion generates larger fees than one managing $8 billion — even if the underlying loans are performing identically.

That creates a specific incentive:

  • Higher internal valuations produce a healthier-looking fund on paper.
  • A healthier-looking fund attracts more capital from new investors.
  • More capital under management generates more fees.
  • The valuations driving all of this are set by the same firm collecting the fees.
"Talk about letting the fox guard the hen house." — Ox Talks

The concern is not that private credit funds make bad loans. The concern is that the reported value of those loans — and by extension the health of the fund as presented to investors — may not reflect market reality. It may reflect what the fund needed the number to be.

📉 The Sequence That Triggered Federal Scrutiny

Earlier this year, TCP Capital issued an off-cycle disclosure — unusual, because these funds typically report quarterly. The disclosure warned investors to expect a 19% markdown in the fund's asset values.

The market reaction was immediate. Shares dropped 13% in a single day — the worst single-day move the fund had seen since March 2020.

The fund later officially recalculated its net asset value at just over $7 per share, down sharply from the $8.71 per share it had reported in the prior period.

What followed: multiple class action lawsuits alleging the fund made materially false statements and failed to properly value its loans.

What comes after that: federal prosecutors asking questions.

Sudden markdown. Class action lawsuits. Federal prosecutors scrutinizing the valuations. That is the sequence. It is worth understanding in order.

🔗 Why One Fund Investigation Becomes an Industry Problem

Approximately a month before this discussion, John Zito — chief of Apollo Global — made an admission that markets largely brushed off at the time.

His statement: "All the marks are wrong."

It was treated as an industry insider making a candid observation. Now, with the DOJ scrutinizing BlackRock's valuation practices at one of the most recognized names in global finance, the comment looks less like candor and more like a preview.

The structural model being questioned at BlackRock TCP is not unique to BlackRock. The same internal valuation committee structure, the same illiquid asset base, and the same fee-tied-to-marks incentive exists across the private credit industry:

  • Blackstone
  • Apollo
  • KKR
  • Blue Owl
  • Ares

When federal prosecutors begin questioning executives at the most prominent name in the space, every fund manager in that space immediately comes under a broader spotlight. The investigation does not need to expand formally for the scrutiny to spread. It already has.

📈 Higher Rates Are Exposing What Low Rates Were Hiding

Private credit expanded dramatically during the era of near-zero interest rates. The combination of cheap capital, abundant liquidity, and investors searching for any yield above what government bonds were offering created ideal conditions for the asset class to grow.

Those conditions have reversed.

Rates are elevated and, as the discussion notes, unlikely to fall significantly in the near term. That creates compounding pressure on the middle market borrowers who obtained these loans:

  • Refinancing becomes more expensive at maturity.
  • Interest coverage ratios deteriorate on floating rate debt.
  • Defaults become more likely as cash flows tighten.
  • Actual loan values decline — which should flow through to fund valuations.
The market environment is becoming less forgiving at the exact moment federal regulators are focusing on whether the valuations being reported ever reflected market reality in the first place.

Both pressures are operating simultaneously. That is not a coincidence in timing. It is the nature of credit cycles — the problems that accumulate during the easy part of the cycle surface during the hard part.

📊 What This Is — and What It Isn't

The discussion is careful about language. The word fraud has not been established. Investigations are underway. Conclusions would be premature.

What is established:

  • A $1.8 billion private credit fund reported a 19% markdown in an off-cycle disclosure, then fell 13% in a single trading day and became the subject of class action lawsuits.
  • Federal prosecutors from the Manhattan U.S. Attorney's Office have brought executives in for questioning about valuation practices.
  • Apollo's chief acknowledged publicly that the marks across the industry are wrong.
  • The incentive structure — fees tied to self-assigned valuations — creates documented conflicts of interest that regulators have been warning about for over a year.

Financial systems can absorb losses. What they cannot absorb as cleanly is loss of trust in the pricing itself. Once investors begin questioning the marks at one major vehicle, they begin questioning everything.

That is the contagion risk. Not the loans. The trust.

💡 Our Commentary / What It Means for Us

At Time Health Capital, the most useful reframe from this discussion is not about BlackRock specifically. It is about what happens when an asset class builds its reputation on numbers that no independent market was checking.

Physicians building toward financial independence have been exactly the demographic that private credit funds have targeted aggressively. High income. Long time horizon. Minimal time to scrutinize the details. A genuine need for yield above what government bonds or money markets offer. The pitch — stable returns, low volatility, institutional-quality lending — fit the profile.

What the pitch did not explain clearly enough is that the stability being reported was inseparable from the valuation methodology producing it. A fund that assigns its own asset values, ties its fees to those values, and reports quarterly is not offering independent verification of its health. It is offering its own assessment of its health.

The financial pressure that distorts medical decision-making operates in the same direction here. When income is under pressure from declining reimbursements and shrinking autonomy, the appeal of a yield-bearing asset that reports consistent stability is powerful. That appeal is exactly when the discipline to understand the structure underneath the pitch matters most.

Three things are worth sitting with:

  • Illiquidity is not the same as stability. A fund that does not trade daily does not experience daily volatility — but that absence of visible volatility is a function of the pricing mechanism, not the underlying asset quality. The 19% markdown at TCP Capital did not represent a sudden deterioration. It represented the moment the reported value was forced to catch up to reality.
  • Fee structures tied to self-assigned valuations are a documented conflict of interest that has been visible for years. The DOJ probe formalizes regulatory attention that Jay Clayton had already signaled publicly. This was not a surprise to those paying attention to the background facts.
  • Higher rates are not creating this problem. They are revealing it. The loans were made during cheap capital conditions. The marks were set during cheap capital conditions. The refinancing stress and default pressure now emerging are the conditions under which the actual quality of those loans gets priced honestly for the first time.

Clarity over noise. Discipline over activity. Long-term positioning over short-term reaction.

The framework that protects capital in this environment is the same one that always does: understand the structure underneath the pitch before committing the capital, not after.

❓ Questions and Implications for Readers

  • Do any of your current investment positions include private credit funds or BDCs where valuations are internally assigned rather than market-determined?
  • If the marks across the private credit industry are wrong — as Apollo's chief stated publicly — what does that imply about the reported stability that made the asset class appealing in the first place?
  • How does illiquidity in your portfolio interact with the financial flexibility you need to navigate declining reimbursements and rising practice costs?
  • When a fund's management fees are calculated on its own reported asset values, what does that incentive structure tell you about how to interpret the stability it reports?

🎥 Prefer to Watch the Full Discussion?

BlackRock Department of Justice Probe Just Announced: The Unwind in Private Credit Has Begun — Ox Talks

💡 Ready to explore real asset strategies? Talk directly with Dr. Ozoude at Time Health Capital.

Schedule a Conversation

Disclaimer: This summary is based on the video "BlackRock Department of Justice Probe Just Announced: The Unwind in Private Credit Has Begun" by Ox Talks. All rights to the original content belong to the creator. Time Health Capital provides this article for educational and informational purposes only, not as investment advice.

Leave a Reply

Your email address will not be published. Required fields are marked *